Target intelligence / Profile preview

CYCS pseudogene 25 (CYCSP25)

Target
CYCSP25
Molecular classification
Pseudogene (specifically, processed pseudogene), Other (does not map to protein families such as GPCR, ion channel, enzyme, etc.)
01

Overview

**CYCS pseudogene 25** is a processed pseudogene that originates from duplication or retrotransposition of the functional CYCS gene, which encodes cytochrome c—a critical mitochondrial electron carrier protein involved in electron transfer and apoptosis in human cells[5][2][4]. CYCSP25 does not encode functional protein and has no direct biological or pharmacological role; it reflects the evolutionary history of the cytochrome c gene family in primates. While its parent gene (CYCS) is well characterized, including roles in apoptosis and mitochondrial processes, the pseudogene itself is annotated in the human genome with aliases HC10 and HCP25, but is not a valid functional or druggable entity[5][1][4]. Processed pseudogenes are common in the human genome and typically lack the ability to produce proteins due to mutations or lack of regulatory sequences. Some pseudogenes can have regulatory effects via interactions with microRNAs or by acting as decoys for regulatory molecules; there is no documented evidence that CYCSP25 has such functions[6]. The functional CYCS gene does have disease relevance (thrombocytopenia), but CYCSP25 does not[2][5].

Other names
HC10HCP25
02

Mechanism of action

null

03

Biological functions

Other (no known direct biological function; pseudogenes may sometimes have regulatory roles, but none are described for CYCSP25 specifically)
04

Disease associations

Other (no direct association with disease; cytochrome c gene mutations are linked to thrombocytopenia, but this does not apply to CYCSP25 itself)

Beyond the preview

Go deeper on CYCS pseudogene 25 (CYCSP25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CYCS pseudogene 25 (CYCSP25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call